| Drug* | Food restrictions | Renal or hepatic modification | Adverse effects |
|---|---|---|---|
| Efavirenz (Sustiva) | Take on empty stomach at bedtime | Renal | Dizziness, insomnia, headache, inability to concentrate, abnormal dreams, lipoatrophy when used with stavudine (Zerit) or zidovudine (Retrovir), potential teratogenicity, false-positive cannabinoid and benzodiazepine screening assays |
| Etravirine (Intelence) | Take with food | None | Nausea, peripheral neuropathy, hypertension, hypersensitivity reaction; increased liver function, increased cholesterol and triglyceride levels |
| Nevirapine (Viramune) | None | Hepatic | Severe hepatotoxicity, liver failure, and death; women with baseline CD4 cell count > 250 per mm3 (0.25 × 109 per L) and men with baseline CD4 > 400 per mm3 (0.40 × 109 per L) are at highest risk |